tiprankstipranks
Taysha Gene Therapies Advances in Rett Syndrome Trials
PremiumCompany AnnouncementsTaysha Gene Therapies Advances in Rett Syndrome Trials
2M ago
Taysha Gene Therapies reports Q3 EPS (10c), consensus (9c)
Premium
The Fly
Taysha Gene Therapies reports Q3 EPS (10c), consensus (9c)
2M ago
TSHA Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
TSHA Earnings this Week: How Will it Perform?
2M ago
Taysha Gene Therapies price target lowered to $6 from $7 at Canaccord
PremiumThe FlyTaysha Gene Therapies price target lowered to $6 from $7 at Canaccord
5M ago
Taysha Gene Therapies reports  Q2 revenue $1.112M, consensus $2.66M
Premium
The Fly
Taysha Gene Therapies reports Q2 revenue $1.112M, consensus $2.66M
5M ago
Options Volatility and Implied Earnings Moves Today, August 12, 2024
Premium
Market News
Options Volatility and Implied Earnings Moves Today, August 12, 2024
5M ago
Taysha Gene Therapies 14.361M share Spot Secondary priced at $2.25
PremiumThe FlyTaysha Gene Therapies 14.361M share Spot Secondary priced at $2.25
7M ago
Taysha Gene Therapies 14.36M share secondary offering priced at $2.25
Premium
The Fly
Taysha Gene Therapies 14.36M share secondary offering priced at $2.25
7M ago
Taysha Gene Therapies falls 12% to $2.16 after filing to sell $75M shares
Premium
The Fly
Taysha Gene Therapies falls 12% to $2.16 after filing to sell $75M shares
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100